| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | FSD Pharma Inc expected to post a loss of 5 cents a share - Earnings Preview | 4 | Reuters | ||
| Di | FSD Pharma Inc (2): FSD submits Lucid-MS application for ethics review | 3 | Stockwatch | ||
| Di | FSD Pharma Inc.: FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 for Ethics Committee Review in Australia | 197 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / May 7, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative... ► Artikel lesen | |
| Di | FSD Pharma Inc. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 30.04. | FSD Pharma Inc (2): FSD Pharma signs agreement with ASPI to conduct trial | 8 | Stockwatch | ||
| 30.04. | FSD Pharma Inc.: FSD Pharma Signs Agreement with Applied Science and Performance Institute to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd in an Induced State of Alcohol Intoxication | 241 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 30, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" of the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative... ► Artikel lesen | |
| 25.04. | FSD Pharma Inc (2): FSD Pharma talks Celly's partnership with Six+One | 7 | Stockwatch | ||
| 25.04. | FSD Pharma Inc.: FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd | 1.527 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu")... ► Artikel lesen | |
| 25.04. | FSD Pharma Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 22.04. | FSD Pharma Inc (2): FSD Pharma talks Celly unbuzzd rollout | 5 | Stockwatch | ||
| 22.04. | FSD Pharma Inc.: FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd | 312 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu")... ► Artikel lesen | |
| 17.04. | FSD Pharma Inc (2): FSD Pharma expands pipeline to metabolic disorders | 5 | Stockwatch | ||
| 17.04. | FSD Pharma Inc.: FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products | 347 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 17, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative... ► Artikel lesen | |
| 17.04. | FSD Pharma Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 15.04. | FSD Pharma Inc.: FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption | 271 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately... ► Artikel lesen | |
| 09.04. | FSD Pharma Inc. - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 08.04. | FSD Pharma Inc (2): FSD Pharma has until Oct. 2 to regain Nasdaq compliance | 1 | Stockwatch | ||
| 08.04. | FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency | 359 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio... ► Artikel lesen | |
| 02.04. | FSD Pharma Inc reports results for the quarter ended in December - Earnings Summary | 6 | Reuters | ||
| 02.04. | FSD Pharma Inc.: FSD Pharma Announces Filing of Year-End 2023 Results | 292 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative... ► Artikel lesen |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.395 |
| BAYER | 1.044 |
| TUI | 1.015 |
| NEL | 948 |
| SIEMENS ENERGY | 820 |
| RHEINMETALL | 627 |
| MERCEDES-BENZ | 619 |
| NVIDIA | 590 |
| DEUTSCHE BANK | 529 |
| NOVAVAX | 470 |
| BYD | 462 |
| PLUG POWER | 453 |
| RWE | 452 |
| ALLIANZ | 432 |
| VOLKSWAGEN | 413 |
| PALANTIR TECHNOLOGIES | 410 |
| K+S | 409 |
| COMMERZBANK | 392 |
| AIXTRON SE | 376 |
| DEUTSCHE LUFTHANSA | 357 |
| BASF | 352 |
| TESLA | 352 |
| THYSSENKRUPP | 338 |
| ALIBABA | 314 |
| NORDEX | 314 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
